[1]
2020. A preliminary report on the use of Midodrine in treating refractory gastroesophageal disease: Randomized Double-Blind Controlled Trial: Midodrine and refractory gastroesophageal disease. Acta Biomedica Atenei Parmensis. 91, 1 (Mar. 2020), 70–78. DOI:https://doi.org/10.23750/abm.v91i1.8486.